Literature DB >> 8676770

How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action.

S G Novick1, J C Godfrey, N J Godfrey, H R Wilder.   

Abstract

Clinical studies have shown that ionic zinc (Zn2+) dissolved in the mouth shortened manifestations of the common cold significantly, by an unknown mechanism. The observed immediate effect on symptoms is consonant with osmotic transport of Zn2+, placing a temporary chemical clamp on critical nerves. It is proposed that transient elevation of Zn2+ concentration in and around the nasal cavity facilitates Zn2+ complexation with known intercellular adhesion molecule binding sites on rhinovirus surfaces which prevents rhinovirus binding to cells and interrupts infection. The crystallographically determined surface of rhinovirus-14 has been found to contain binding sites for at least 360 Zn2+. Such binding of Zn2+ would be stabilized by numerous histidine, methionine, tyrosine and carboxyl/carboxylate groups known to line the HRV-14 surface canyons. The resulting blockage of HRV docking with intercellular adhesion molecule binding sites is proposed to be responsible for the observed reduction of the duration of colds by statistically significant and clinically meaningful times.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676770     DOI: 10.1016/s0306-9877(96)90259-5

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  18 in total

Review 1.  Treatment of the common cold.

Authors:  S B Mossad
Journal:  BMJ       Date:  1998-07-04

Review 2.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Zinc salts inactivate clinical isolates of herpes simplex virus in vitro.

Authors:  M Arens; S Travis
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 4.  Complementary and alternative medicine for prevention and treatment of the common cold.

Authors:  Richard Nahas; Agneta Balla
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

5.  In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.

Authors:  D L Barnard; V D Hubbard; D F Smee; R W Sidwell; K G W Watson; S P T Tucker; P A R Reece
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 6.  Zinc gluconate and the common cold. Review of randomized controlled trials.

Authors:  S Marshall
Journal:  Can Fam Physician       Date:  1998-05       Impact factor: 3.275

Review 7.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 8.  Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Michelle Science; Jennie Johnstone; Daniel E Roth; Gordon Guyatt; Mark Loeb
Journal:  CMAJ       Date:  2012-05-07       Impact factor: 8.262

9.  Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold.

Authors:  Mostafa Yakoot; Amel Salem
Journal:  Int J Gen Med       Date:  2011-01-12

10.  The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  BMC Fam Pract       Date:  2015-02-25       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.